Your browser doesn't support javascript.
loading
SIRT1-modified human umbilical cord mesenchymal stem cells ameliorate experimental peritoneal fibrosis by inhibiting the TGF-ß/Smad3 pathway.
Guo, Yanhong; Wang, Liuwei; Gou, Rong; Wang, Yulin; Shi, Xiujie; Pang, Xinxin; Tang, Lin.
Afiliación
  • Guo Y; Department of Nephropathy, The First Affiliated Hospital of Zhengzhou University, No. 1 East Jianshe Road, Zhengzhou, 450052, Henan, China.
  • Wang L; Department of Nephropathy, The First Affiliated Hospital of Zhengzhou University, No. 1 East Jianshe Road, Zhengzhou, 450052, Henan, China.
  • Gou R; Department of Nephropathy, The First Affiliated Hospital of Zhengzhou University, No. 1 East Jianshe Road, Zhengzhou, 450052, Henan, China.
  • Wang Y; Department of Nephropathy, The First Affiliated Hospital of Zhengzhou University, No. 1 East Jianshe Road, Zhengzhou, 450052, Henan, China.
  • Shi X; Department of Nephropathy, Henan Provincial Hospital of Traditional Chinese Medicine (The Second Hospital Affiliated to Henan University of Chinese Medicine), No. 6, Dong Feng Road, Jinshui District, Zhengzhou, 450002, Henan, China.
  • Pang X; Department of Nephropathy, Henan Provincial Hospital of Traditional Chinese Medicine (The Second Hospital Affiliated to Henan University of Chinese Medicine), No. 6, Dong Feng Road, Jinshui District, Zhengzhou, 450002, Henan, China. doctorpang@aliyun.com.
  • Tang L; Department of Nephropathy, The First Affiliated Hospital of Zhengzhou University, No. 1 East Jianshe Road, Zhengzhou, 450052, Henan, China. tanglin@zzu.edu.cn.
Stem Cell Res Ther ; 11(1): 362, 2020 08 18.
Article en En | MEDLINE | ID: mdl-32811535

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fibrosis Peritoneal / Células Madre Mesenquimatosas Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Stem Cell Res Ther Año: 2020 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fibrosis Peritoneal / Células Madre Mesenquimatosas Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Stem Cell Res Ther Año: 2020 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido